Atika Capital Management’s Medicines Co MDCO Stock Holding History

Atika Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-124,000	Closed	-$8.27M	–	97
2019 Q3	$6.2M	Buy	124,000 +53,000	+75%	+$2.11M	1.31%	32
2019 Q2	$2.59M	Buy	+71,000	New	+$2.32M	0.51%	66
2018 Q4	–	Sell	-20,000	Closed	-$465K	–	107
2018 Q3	$599K	Buy	20,000 +9,187	+85%	+$346K	0.11%	84
2018 Q2	$396K	Buy	+10,813	New	+$351K	0.08%	88
2017 Q4	–	Sell	-78,000	Closed	-$2.89M	–	90
2017 Q3	$2.89M	Sell	78,000 -112,000	-59%	-$4.13M	0.83%	49
2017 Q2	$7.22M	Buy	190,000 +114,000	+150%	+$5.08M	2.53%	8
2017 Q1	$3.72M	Buy	76,000 +32,000	+73%	+$1.46M	1.82%	19
2016 Q4	$1.49M	Sell	44,000 -21,000	-32%	-$745K	0.89%	44
2016 Q3	$2.45M	Buy	+65,000	New	+$2.45M	1%	40

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Atika Capital Management's MDCO Position: Q4 2019 in Review

Atika Capital Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 124,000 shares — an estimated $8.27M sold.

Atika Capital Management first reported a position in MDCO in Q3 2016 and held it in 9 quarters. The position peaked at $7.22M in Q2 2017. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Atika Capital Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Atika Capital Management sold 124,000 Medicines Co shares in Q4 2019, an estimated $8.27M.
Atika Capital Management first reported a position in Medicines Co in Q3 2016 and held it in 9 quarters.
Atika Capital Management's Medicines Co position peaked at $7.22M in Q2 2017.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Atika Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.